International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser

Author(s): Christiansen Joel, White Lyndell

Issue: Jul/Aug 2010 - Sterile Compounding
View All Articles in Issue

Page(s): 310-314

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 1

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 2

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 3

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 4

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 5

Download in electronic PDF format for $75

Abstract: Compounding pharmacists can provide a great therapeutic service to pain management patients who have overcome an addiction to prescribed or illegal drugs or alcohol. By collaborating with the physician and the patient, the compounder can develop an effective analgesic formulation with no addictive potential; a preparation that can be safely adjusted to meet changing medical needs. In this report, we present a personal account of the value of two compounded preparations that relieve severe musculoskeletal pain without producing mood-altering effects, as well as information about how those compounds are prepared.

Related Keywords: Joel Christiansen, EdS, Lyndell White, PharmD, RP, pain control, substance abuse, drug addicts, addiction recovery, analgesic, analgesia, formulation, muscle pain, ketoprofen, lidocaine, cyclobenzaprine hydrochloride, topical preparations, transdermal administration

Related Categories: FORMULATIONS, MENTAL HEALTH, PAIN MANAGEMENT, DOSAGE FORMS/DRUG CARRIERS, MUSCULOSKELETAL DISORDERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Christiansen Joel, White Lyndell	Jul/Aug 2010 Pg. 310-314
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Gilbert John A	Sep/Oct 2009 Pg. 400-403
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Mar/Apr 2024 Pg. 100-109
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jul/Aug 2015 Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Mar/Apr 2024 Pg. 111-116
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Managing Pain with Transdermal Ketoprofen Williams KaCee D	May/Jun 2010 Pg. 204-206
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Pore R David	Nov/Dec 2012 Pg. 446-450
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Warner Meredith, Tuder Dmitry	May/Jun 2014 Pg. 182-188
Update on Managing Neuropathic Pain McNulty Jack P, Muller George	May/Jun 2009 Pg. 182-190
Levorphanol for the Treatment of Severe Chronic Pain McNulty Jack P	May/Jun 2007 Pg. 202-211
Case Reports: Compounding to Relieve Arthritis Pain Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane	Nov/Dec 2008 Pg. 498-504
Compounding with Controlled Substances Whalen Mary Kate	Jan/Feb 2002 Pg. 8-10
Drug Therapy for Acute and Chronic Pain in the Cat Lascelles B Duncan	Sep/Oct 2002 Pg. 338-343
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report McNulty Jack P, Hahn Kristian	Sep/Oct 2012 Pg. 364-368
Return to Top